section name header

Information

Hemoglobin Electrophoresis and Abnormal Hemoglobins

Synonym/Acronym

Hemoglobin F (fetal hemoglobin), hemoglobin S (sickle cell test), methemoglobin (hemoglobin M, MetHb, Hgb M).

Rationale

To assist in evaluating hemolytic anemias and identifying hemoglobin variants, diagnose thalassemias and sickle cell anemia. To assess for cyanosis and hypoxemia associated with pathologies affecting hemoglobin.

Patient Preparation

There are no food, fluid, activity, or medication restrictions unless by medical direction.

Normal Findings

Method: Electrophoresis for hemoglobin (Hgb) electrophoresis. Spectrophotometry for methemoglobin. Hemoglobin high-salt solubility for sickle cell screen.

Hgb A
AdultGreater than 95%
Hgb A2
Adult1.5%–3.7%
Hgb CNone
Hgb DNone
Hgb ENone
Hgb F
Newborns and infants
1 day–3 wk70%–77%
6–9 wk42%–64%
3–4 mo7%–39%
6 mo3%–7%
8–11 mo0.6%–2.6%
Adult–older adultLess than 2%
Hgb HNone
Methemoglobin (Hgb M)Less than 1% of total Hgb
Hgb S (sickle cell screen)None (negative screen)

Critical Findings and Potential Interventions

Methemoglobin

Cyanosis can occur at levels greater than 10%.

Dizziness, fatigue, headache, and tachycardia can occur at levels greater than 30%.

Signs of central nervous system depression can occur at levels greater than 45%.

Death may occur at levels greater than 70%.

Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.

Possible interventions include airway protection, administration of oxygen, monitoring neurological status every hour, continuous pulse oximetry, hyperbaric oxygen therapy, and exchange transfusion. Administration of activated charcoal or gastric lavage may be effective if performed soon after the toxic material is ingested. Emesis should never be induced in patients with no gag reflex because of the risk of aspiration. Methylene blue may be used to reverse the process of methemoglobin formation, but it should be used cautiously when methemoglobin levels are greater than 30%. Use of methylene blue is contraindicated in the presence of glucose-6-phosphate dehydrogenase deficiency.

Overview

Study type: Blood collected in a lavender-top [EDTA] tube; related body system: Circulatory/Hematopoietic system. The specimen should be placed in an ice slurry immediately after collection. Information on the specimen label should be protected from water in the ice slurry by first placing the specimen in a protective plastic bag. The specimen should be promptly transported to the laboratory for processing and analysis.

Hgb electrophoresis is a separation process used to identify normal and abnormal forms of Hgb. Electrophoresis and high-performance liquid chromatography as well as molecular genetics testing for mutations can also be used to identify abnormal forms of Hgb. Hgb A is the main form of Hgb in the healthy adult. Hgb F is the main form of Hgb in the fetus, the remainder being composed of Hgb A1 and A2. Small amounts of Hgb F are normal in the adult. Hgb C, D, E, H, and S result from abnormal amino acid substitutions during the formation of Hgb and are inherited hemoglobinopathies.

Hgb M is a structural Hgb variant that can be inherited or acquired. It is formed when the heme portion of the deoxygenated Hgb is oxidized to a ferric state rather than to the normal ferrous state, rendering it incapable of combining with and transporting oxygen to tissues. Visible cyanosis can result as levels approach 10% to 15% of total Hgb.

The sickle cell screen is one of several screening tests for a group of hereditary hemoglobinopathies. The test is positive in the presence of rare sickling Hgb variants such as Hgb S and Hgb C Harlem. Electrophoresis and high-performance liquid chromatography as well as molecular genetics testing for beta-globin mutations can also be used to identify Hgb S. Hgb S results from an amino acid substitution during Hgb synthesis whereby valine replaces glutamic acid. Hgb C Harlem results from the substitution of lysine for glutamic acid. Individuals with sickle cell disease have chronic anemia because the abnormal Hgb is unable to carry oxygen. The red blood cells (RBCs) of affected individuals are also abnormal in shape, resembling a crescent or sickle rather than the normal disk shape. This abnormality, combined with cell-wall rigidity, prevents the cells from passing through smaller blood vessels. Blockages in blood vessels result in hypoxia, damage, and pain.

Preconception (maternal and paternal), prenatal, and antenatal hemoglobin electrophoresis screening has become routine practice especially in ethnic populations with a high prevalence for sickle cell anemia, sickle cell disease, and thalassemia in order to detect abnormal hemoglobins. Repeat hemoglobin electrophoresis testing in patients with a known hemoglobinopathy is unnecessary unless it is needed to make a more specific diagnosis or to monitor therapeutic effectiveness.

Knowledge of genetics assists in identifying those who may benefit from additional education, risk assessment, and counseling. Genetics is the study and identification of genes, genetic mutations, and inheritance. For example, genetics provides some insight into the likelihood of inheriting a medical condition such as a hemoglobinopathy like sickle cell anemia. Some conditions are the result of mutations involving a single gene, whereas other conditions may involve multiple genes and/or multiple chromosomes. Sickle cell disease is an example of an autosomal recessive disorder in which the offspring inherits a copy of the defective gene from each parent. Individuals with the sickle cell trait do not have the clinical manifestations of the disease but may pass the disease on to children if the other parent has the trait (or the disease) as well. Further information regarding inheritance of genes can be found in the study titled “Genetic Testing.”

Indications

Hgb Electrophoresis

Methemoglobin

Sickle Cell Screen

Interfering Factors

Hgb Electrophoresis

Factors That May Alter the Results of the Study

  • High altitude (related to a compensatory mechanism whereby RBC production is increased to increase availability of oxygen binding to Hgb) and dehydration (related to hemoconcentration) may increase values.
  • Iron deficiency may decrease Hgb A2, C, and S (related to decreased amounts of Hgb in smaller, iron-deficient RBCs).
  • In patients less than 3 mo of age, false-negative results for Hgb S occur in coincidental polycythemia (related to technical limitations of the procedure where increased total Hgb levels reflect a small, possibly undetectable percentage of Hgb S when compared to large amounts of Hgb F).
  • RBC transfusion within 4 mo of test can mask abnormal Hgb levels.

Hgb S by Sickle Cell Screen

Factors That May Alter the Results of the Study

  • A positive test does not distinguish between the sickle trait and sickle cell anemia; to make this determination, follow-up testing by Hgb electrophoresis should be performed.
  • False-negative results may occur in children younger than 3 mo of age.
  • False-negative results may occur in patients who have received a recent blood transfusion before specimen collection, as a result of the dilutional effect.
  • False-positive results may occur in patients without the trait or disease who have received a blood transfusion from a sickle cell–positive donor; this effect can last for 4 mo after the transfusion.

Other Considerations

  • Test results are unreliable if the patient has pernicious anemia or polycythemia.

Methemoglobin

Factors That May Alter the Results of the Study

  • Drugs and other substances that may increase methemoglobin levels include amyl nitrate, benzocaine, dapsone, isoniazid, phenytoin, silver nitrate, and sulfonamides.

Other Considerations

  • Well water containing nitrate is the most common cause of methemoglobinemia in infants.
  • Breastfeeding infants are capable of converting inorganic nitrate from common topical anesthetic applications containing nitrate to the nitrite ion, causing nitrite toxicity and increased methemoglobin.
  • Prompt and proper specimen processing, storage, and analysis are important to achieve accurate results. Methemoglobin is unstable and should be transported on ice within a few hours of collection, or else the specimen should be rejected.

Potential Medical Diagnosis: Clinical Significance of Results

Increased In

Hemoglobin Electrophoresis

Hgb A2

Hgb C

  • Hgb C disease (one of the most common structural variants in the human population; has a higher prevalence among people of African ancestry)

Hgb D

  • Hgb D (rare hemoglobinopathy that may also be found in combination with Hgb S or thalassemia)

Hgb E

  • Hgb E disease; thalassemia-like condition (second-most common hemoglobinopathy in the world; occurs with the highest frequency in people of South Asian [India, Bangladesh], Southeast Asian [Thailand, Laos, Cambodia], and African ancestry, where it is common for individuals to inherit alleles for both Hgb E and beta-thalassemia)

Hgb F

Hgb H

Hgb S

  • Sickle cell trait or disease (most common variant in the United States; occurs with a frequency of about 8% among people of African ancestry)

Methemoglobin

  • Acquired methemoglobinemia (drugs, tobacco smoking, or ionizing radiation)
  • Carbon monoxide poisoning(carbon monoxide is a form of deoxygenated hemoglobin)
  • Hereditary methemoglobinemia(evidenced by a deficiency of NADH-methemoglobin reductase or related to the presence of a hemoglobinopathy)

Hgb S by Sickle Cell Screen

Deoxygenated Hgb S is insoluble in the presence of a high-salt solution and will form a cloudy turbid suspension when present.

  • Combination of Hgb S with other hemoglobinopathies
  • Hgb C Harlem anemia
  • Sickle cell anemia
  • Sickle cell trait
  • Thalassemias

Decreased In

Hemoglobin Electrophoresis

Hgb A2

Nursing Implications, Nursing Process, Clinical Judgement

Before the Study: Planning and Implementation

Teaching the Patient What to Expect

  • Discuss how this test can assist in diagnosing various types of anemias and identifying the cause of poor oxygenation.
  • Explain that a blood sample is needed for the test.

After the Study: Implementation & Evaluation Potential Nursing Actions

Treatment Considerations

  • Discuss the pathophysiology of sickle cell disease in understandable terms.
  • Explain that the frequency of sickling crises is related to disease management and the need for review of therapeutic management strategies.
  • Advise the patient with sickle cell disease to avoid situations in which hypoxia may occur, such as strenuous exercise, staying at high altitudes, or traveling in an unpressurized aircraft.
  • Obstetric patients are at risk for hypoxia during the stress of labor and delivery; surgical patients may become hypoxic while under general anesthesia. Both groups should be closely monitored.
  • Instruct the patient with methemoglobinemia to avoid carbon monoxide from firsthand or secondhand smoking, to have home gas furnace checked yearly for leaks, and to use gas appliances such as gas grills in a well-ventilated area.
  • Facilitate collaboration between the HCP and patient to identify acceptable pain management strategies. Some of those strategies are judicious application of heat or cold, administration of ordered analgesics (morphine, hydromorphone, NSAIDS), blood transfusion, joint support, and distraction.
  • Mobility can become a problem in the presence of pain, fear of pain, and anxiety. Emotional support, activity premedication, and the implementation of assistive devices can facilitate mobility.

Clinical Judgement

  • Consider how to discuss treatment options in such a way that decreases fear associated with the disease outcomes.

Follow-Up and Desired Outcomes